2024 Inzy stock forecast - Find the latest MAIA Biotechnology, Inc. (MAIA) stock quote, history, news and other vital information to help you with your stock trading and investing.

 
Inozyme Pharma, Inc. (INZY) stock forecast and price target. Find the latest Inozyme Pharma, Inc. INZY analyst stock forecast, price target, and recommendation trends with in-depth analysis from ... . Inzy stock forecast

Find real-time PAYC - Paycom Software Inc stock quotes, company profile, news and forecasts from CNN Business.Nasdaq Futures -44.75(-0.28%) Russell 2000 Futures 1,798.80 -12.20(-0.67%) Crude Oil 74.30 -1.24(-1.64%) Gold 2,013.20 +10.20(+0.51%) Inozyme Pharma, Inc. (INZY) NasdaqGS - NasdaqGS Real Time... 24 Wall Street research analysts have issued 1 year target prices for Walt Disney's shares. Their DIS share price targets range from $76.00 to $136.00. On average, they expect the company's stock price to reach $108.95 in the next twelve months. This suggests a possible upside of 14.5% from the stock's current price.People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.Mar 23, 2023 · Analyst Price Forecast Suggests 489.65% Upside As of March 24, 2023, the average one-year price target for Inozyme Pharma is $19.46. The forecasts range from a low of $4.54 to a high of $42.00. Inozyme Pharma falls after updates to rare disease program. Jul. 26, 2023 10:24 AM ET Inozyme Pharma, Inc. (INZY) By: Dulan Lokuwithana, SA News Editor. mphillips007. Inozyme Pharma ( NASDAQ: INZY ...Nov 13, 2023 · Inozyme Pharma's earnings are forecast to decline at 9.3% per annum while its annual revenue is expected to grow at 95.9% per year. EPS is expected to grow by 5.5% per annum. Find the latest Fangdd Network Group Ltd. (DUO) stock quote, history, news and other vital information to help you with your stock trading and investing.Price Performance Review of INZY. On Monday, Inozyme Pharma Inc [NASDAQ:INZY] saw its stock fall -5.97% to $2.99. On the same session, the stock had its day’s lowest price of $2.97, but rose to a high of $3.22. Over the last five days, the stock has gained 2.05%. Inozyme Pharma Inc shares have risen nearly 184.76% since the year began.Earnings for Incyte are expected to grow by 28.00% in the coming year, from $3.00 to $3.84 per share. Incyte has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 6th, 2024 based off prior year's report dates. Read More.Find out why INZY stock is a Hold. ... In a pre-revenue phase, evident by the consistent zero sales forecast, their growth is underpinned by the developmental stage of their drug, INZ-701 ...Incyte Corp (INCY) Stock Forecast: Potential 26.29% Increase and Next Earnings Report. On July 24, 2023, Incyte Corp (INCY) stock had a median target price forecast of $81.00, according to 16 analysts. The high estimate was $109.00, while the low estimate was $60.00. This median estimate represented a 26.29% increase from the last …Inozyme Pharma, Inc. (INZY) share price prediction for 2023, 2024, 2025, 2026 and 2027. INZY one year forecast. Inozyme Pharma stock monthly and weekly forecasts.Find the latest Dogecoin USD (DOGE-USD) price quote, history, news and other vital information to help you with your cryptocurrency trading and investing.All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange ...Stockinvest.us Pricing Options. Stockinvest.us has a single pricing tier and costs 19.90/month or $199/year. There is also a five-day free trial for new users to try out the software. When you first sign up for the free trial, Stockinvest.us offers 20% off a plan for up to 24 hours. Try StockInvest.us for Free!Find the latest Earnings Report Date for Incyte Corp. Common Stock (INCY) at Nasdaq.com.In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according ...16 analysts have issued twelve-month price objectives for Alibaba Group's shares. Their BABA share price targets range from $90.00 to $150.00. On average, they expect the company's share price to reach $129.20 in the next year. This suggests a possible upside of 74.6% from the stock's current price.View Inozyme Pharma, Inc INZY investment & stock information. Get the latest Inozyme Pharma, Inc INZY detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Dec 1, 2023 · Analyst Forecast According to 16 analysts, the average rating for INCY stock is "Buy." The 12-month stock price forecast is $79.25, which is an increase of 46.71% from the latest price. Find the latest Atreca, Inc. (BCEL) stock quote, history, news and other vital information to help you with your stock trading and investing.Dec 2, 2023 · The consensus price target of analysts on Wall Street is $21.00, which implies an increase of 81.67% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $15.00 and $40.00 respectively. As a result, INZY is trading at a discount of -938.96% off the target high and -289.61% off the low. Track Inozyme Pharma Inc (INZY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsYou can buy or sell Inozyme Pharma and other ETFs, options, and stocks. View the real-time INZY price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper statement fees may apply. See Robinhood Financial’s fee schedule ...President exercised options and sold US$65k worth of stock Jun 26. Inozyme Pharma, Inc. Announces Acceptance of First European Clinical Trial Application …Nasdaq Futures -44.75(-0.28%) Russell 2000 Futures 1,798.80 -12.20(-0.67%) Crude Oil 74.30 -1.24(-1.64%) Gold 2,013.20 +10.20(+0.51%) Inozyme Pharma, Inc. (INZY) NasdaqGS - NasdaqGS Real Time...Nasdaq Futures -44.75(-0.28%) Russell 2000 Futures 1,798.80 -12.20(-0.67%) Crude Oil 74.30 -1.24(-1.64%) Gold 2,013.20 +10.20(+0.51%) Inozyme Pharma, Inc. (INZY) NasdaqGS - NasdaqGS Real Time...Based on short-term price targets offered by 15 analysts, the average price target for Incyte comes to $78.00. The forecasts range from a low of $59.00 to a high of $93.00. The average price ...The U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the...Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $12.95B. -12.7%. Market Cap / Employee. The market cap of a ...The Incyte Corporation stock price gained 0.637% on the last trading day (Friday, 24th Nov 2023), rising from $53.40 to $53.74. During the last trading day the stock fluctuated 1.08% from a day low at $53.21 to a day high of $53.78. The price has risen in 7 of the last 10 days and is up by 2.32% over the past 2 weeks.We feed our Machine Learning (AI based) forecast algorithm data from the most influential global exchanges. There are a number of existing AI-based platforms that try to predict the future of Stock markets. They include data research on historical volume, price movements, latest trends and compare it with the real-time performance of the market.Oct 27, 2023 · Price Prediction Incyte price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions. See the latest Incyte Corp stock price (INCY:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Find the latest MEI Pharma, Inc. (MEIP) stock quote, history, news and other vital information to help you with your stock trading and investing.BOSTON, March 15, 2022 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics …Stock Price Forecast. According to 16 stock analysts, the average 12-month stock price forecast for Incyte stock is $79.25, which predicts an increase of 47.47%. The lowest target is $60 and the highest is $100. On average, analysts rate Incyte stock as a buy.Incyte Corp Revenue Forecast for 2023 - 2025 - 2030. Incyte Corp's Revenue has seen impressive growth In the last three years, rising from $2.16B to $3.39B – a growth of 57.25%. In the next year, analysts believe that Revenue will reach $3.93B – an increase of 15.71%. For the next eight years, the forecast is for Revenue to grow by 16.18%.All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange ...On December 4, 2023, Incyte (NASDAQ:INCY) received a significant boost as Guggenheim analyst Michael Schmidt upgraded the company’s rating from Neutral to Buy. Schmidt set a price target of $86.00 for the stock, indicating a positive outlook on Incyte’s performance. This upgrade aligns with the consensus among analysts, who have an average rating of …Free cash flow. Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. 154.20M. -37.63%. Get the latest Incyte Corporation (INCY) real-time ... The Incyte Corp. stock forecast for tomorrow is $ 53.83, which would represent a 0.02% gain compared to the current price. In the next week, the price of INCY is expected to increase by 4.07% and hit $ 56.01. As far as the long-term Incyte Corp. stock forecast is concerned, here’s what our predictions are currently suggesting.Track Inozyme Pharma Inc (INZY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors According to the issued ratings of 19 analysts in the last year, the consensus rating for Incyte stock is Hold based on the current 1 sell rating, 10 hold ratings and 8 buy ratings for INCY. The average twelve-month price prediction for Incyte is $79.94 with a high price target of $100.00 and a low price target of $61.00. Find the latest China SXT Pharmaceuticals, Inc. (SXTC) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Cano Health, Inc. (CANO) stock quote, history, news and other vital information to help you with your stock trading and investing.The Incyte Corp. stock forecast for tomorrow is $ 53.83, which would represent a 0.02% gain compared to the current price. In the next week, the price of INCY is expected to increase by 4.07% and hit $ 56.01. As far as the long-term Incyte Corp. stock forecast is concerned, here’s what our predictions are currently suggesting.Dec 1, 2023 · 16 analysts have issued twelve-month price objectives for Alibaba Group's shares. Their BABA share price targets range from $90.00 to $150.00. On average, they expect the company's share price to reach $129.20 in the next year. This suggests a possible upside of 74.6% from the stock's current price. The 16 Wall Street analysts offering INCYTE CORP stock forecast in the last 6 months have average price target of $78.88 with a high forecast of $98.0 and a low forecast of $63.0. The average INCYTE CORP stock forecast represents a 46.78% increase from the last price of $53.7400016784668.Find the latest MEI Pharma, Inc. (MEIP) stock quote, history, news and other vital information to help you with your stock trading and investing.For Sorrento Therapeutics stock forecast for 2023, 8 predictions are offered for each month of 2023 with average Sorrento Therapeutics stock forecast of $0.76, a high forecast of $1.2, and a low forecast of $0.36. The average Sorrento Therapeutics stock forecast 2023 represents a 127.59% increase from the last price of $0.332199990749359. Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Inozyme Pharma Inc have a median target of 16.00, with a high estimate of 40.00 and a low estimate of 15.00. The median ... Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level. Try it Free. Find the latest Incyte Corporation (INCY) stock forecast based ...Inozyme Pharma's earnings are forecast to decline at 9.3% per annum while its annual revenue is expected to grow at 95.9% per year. EPS is expected to grow by 5.5% per annum.Stockinvest.us Pricing Options. Stockinvest.us has a single pricing tier and costs 19.90/month or $199/year. There is also a five-day free trial for new users to try out the software. When you first sign up for the free trial, Stockinvest.us offers 20% off a plan for up to 24 hours. Try StockInvest.us for Free!Based on 12 Wall Street analysts offering 12 month price targets for Incyte in the last 3 months. The average price target is $82.64 with a high forecast of $93.00 and a low forecast of $63.00. The average price target represents a 53.24% change from the last price of $53.93. Highest Price Target $93.00. Average Price Target $82.64.We feed our Machine Learning (AI based) forecast algorithm data from the most influential global exchanges. There are a number of existing AI-based platforms that try to predict the future of Stock markets. They include data research on historical volume, price movements, latest trends and compare it with the real-time performance of the market. Find the latest Pyxis Oncology, Inc. (PYXS) stock quote, history, news and other vital information to help you with your stock trading and investing.Inozyme Pharma falls after updates to rare disease program. Jul. 26, 2023 10:24 AM ET Inozyme Pharma, Inc. (INZY) By: Dulan Lokuwithana, SA News Editor. mphillips007. Inozyme Pharma ( NASDAQ: INZY ...Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Inozyme Pharma Inc have a median target of 16.00, with a high estimate of 40.00 and a low estimate of 15.00. The median ... 4 Wall Street research analysts have issued 12 month price targets for Argo Blockchain's stock. Their ARBK share price targets range from $1.45 to $2.75. On average, they expect the company's stock price to reach $2.23 in the next twelve months. This suggests a possible upside of 90.9% from the stock's current price.Federated Hermes: bullish, S&P 500 price target of 5,000. Strong underlying trends in the stock market are likely to extend well into 2024, according to Federated …Find the latest Kintara Therapeutics, Inc. (KTRA) stock quote, history, news and other vital information to help you with your stock trading and investing.For the current quarter, INZY is expected to report an EPS forecast of -$0.45. In terms of annual financials, INZY reported an annual revenue of $0.00 for the last year and an annual profit of -$67.1 million. INZY Stock Shows Promising Performance on August 9, 2023: Optimistic Price Forecasts and Unanimous Buy Rating. INZY stock, belonging to ...Find the latest Vaxart, Inc. (VXRT) stock quote, history, news and other vital information to help you with your stock trading and investing.Nov 29, 2023 · According to the issued ratings of 4 analysts in the last year, the consensus rating for Inozyme Pharma stock is Buy based on the current 4 buy ratings for INZY. The average twelve-month price prediction for Inozyme Pharma is $15.00 with a high price target of $23.00 and a low price target of $6.00. Learn more on INZY's analyst rating history. Incyte Corp (INCY) Stock Forecast: Potential 26.29% Increase and Next Earnings Report. On July 24, 2023, Incyte Corp (INCY) stock had a median target price forecast of $81.00, according to 16 analysts. The high estimate was $109.00, while the low estimate was $60.00. This median estimate represented a 26.29% increase from the last …Find the latest Institutional Holdings data for Inozyme Pharma, Inc. Common Stock (INZY) at Nasdaq.com.Free cash flow. Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. 154.20M. -37.63%. Get the latest Incyte Corporation (INCY) real-time ... 16 analysts have issued twelve-month price objectives for Alibaba Group's shares. Their BABA share price targets range from $90.00 to $150.00. On average, they expect the company's share price to reach $129.20 in the next year. This suggests a possible upside of 74.6% from the stock's current price.People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.Bannister’s mid-year 2024 forecast implies that the index may have a hard time rising more than 2% from current levels. The U.S. stock market was down on …NVVE | Complete Nuvve Holding Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.The core CPI, excluding food and energy, rose 4.8% from the prior year, also slowing from 5.3% in May and below the consensus forecast. The Dow rose 0.8%, the S&P 1.0%, and the Nasdaq 1.4%. Crude ... Find the latest Troika Media Group, Inc. (TRKA) stock quote, history, news and other vital information to help you with your stock trading and investing.Oct 13, 2023 · Incyte stock price predictions for 2023, 2024, 2025, 2026, 2027 using artificial intelligence. How much will Incyte cost in 2021-2025? Oct 26, 2023 · Price Prediction forecast forIncyte to October 27, and an in-depth analysis for the week of 22 October to 28 October. Monthly forecasts INCY for 2023 with target levels, support & resistance insights to make informed investment decisions. Turning to the calls side of the option chain, the call contract at the $57.50 strike price has a current bid of 65 cents. If an investor was to purchase shares of INCY stock at the current price ...Inzy stock forecast

INZY stock had a strong performance on September 27, 2023, based on the information provided by CNN Money. The 12-month price forecasts from 6 analysts for Inozyme Pharma Inc have a median target of $16.00, with a high estimate of $40.00 and a low estimate of $15.00.. Inzy stock forecast

inzy stock forecast

Dec 1, 2023 · 19 Wall Street analysts have issued 1-year price objectives for Incyte's stock. Their INCY share price targets range from $61.00 to $100.00. On average, they expect the company's share price to reach $79.94 in the next year. This suggests a possible upside of 48.0% from the stock's current price. Find the latest Eargo, Inc. (EAR) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Spyre Therapeutics, Inc. (AGLE) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Phathom Pharmaceuticals, Inc. (PHAT) stock quote, history, news and other vital information to help you with your stock trading and investing.Incyte Stock (NASDAQ:INCY), Analyst Ratings, Price Targets, Predictions. Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if ...If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.Nov 14, 2023 · Inozyme Pharma Stock Forecast and Price Target. The average price target for Inozyme Pharma's stock set by recognized analysts recently is $23.00, which would result in a potential upside of approximately 701.39% if it reached this mark. The estimation is based on a high estimate of $40.00 and a low estimate of $5.00. Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $12.95B. -12.7%. Market Cap / Employee. The market cap of a ...Find the latest Mobile Global Esports Inc. (MGAM) stock quote, history, news and other vital information to help you with your stock trading and investing.Earnings for Inozyme Pharma are expected to decrease in the coming year, from ($1.34) to ($1.35) per share. Inozyme Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 27th, 2024 based off prior year's report dates. Read More.In this article, we answer “what is sales forecasting?” by breaking down its objectives, owners, methods, and best practices. Sales | What is REVIEWED BY: Jess Pingrey Jess served on the founding team of a successful B2B startup and has use...Find the latest Bit Digital, Inc. (BTBT) stock quote, history, news and other vital information to help you with your stock trading and investing.View live Inozyme Pharma, Inc. chart to track its stock's price action. Find market predictions, INZY financials and market news. Search. Products; Community; Markets; News; ... Market closed Market closed. No trades. See on Supercharts. Overview . News Ideas Financials Technicals Forecast . INZY chart. Today 6.22% 5 days 20.55% 1 …Nov 29, 2023 · According to the issued ratings of 4 analysts in the last year, the consensus rating for Inozyme Pharma stock is Buy based on the current 4 buy ratings for INZY. The average twelve-month price prediction for Inozyme Pharma is $15.00 with a high price target of $23.00 and a low price target of $6.00. Learn more on INZY's analyst rating history. Inozyme Pharma Stock Chart and Share Price Forecast, Short-Term "INZY" Stock Prediction for Next Days and Weeks Walletinvestor.com Inozyme Pharma Inc (INZY) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024Nov 30, 2022 · Find the latest Incyte Corporation (INCY) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Inozyme Pharma Inc have a median target of 16.00, with a high estimate of 40.00 and a low estimate of 15.00. The median ... Nov 24, 2023 · According to 4 stock analysts, the average 12-month stock price forecast for Inozyme Pharma stock is $15, which predicts an increase of 281.68%. The lowest target is $6.00 and the highest is $23. On average, analysts rate Inozyme Pharma stock as a strong buy. Price Prediction Incyte price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions.Dec 1, 2023 · 16 analysts have issued twelve-month price objectives for Alibaba Group's shares. Their BABA share price targets range from $90.00 to $150.00. On average, they expect the company's share price to reach $129.20 in the next year. This suggests a possible upside of 74.6% from the stock's current price. View the latest Incyte Corp. (INCY) stock price, news, historical charts, analyst ratings and financial information from WSJ. Find the latest Inozyme Pharma, Inc. (INZY) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Incyte Corporation (INCY) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo FinanceInozyme Pharma, Inc. Common Stock (INZY) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.Nasdaq Futures -44.75(-0.28%) Russell 2000 Futures 1,798.80 -12.20(-0.67%) Crude Oil 74.30 -1.24(-1.64%) Gold 2,013.20 +10.20(+0.51%) Inozyme Pharma, Inc. (INZY) NasdaqGS - NasdaqGS Real Time...View the latest Incyte Corp. (INCY) stock price, news, historical charts, analyst ratings and financial information from WSJ. Nov 21, 2023 · Incyte is forecast to grow earnings and revenue by 30.9% and 10.8% per annum respectively. EPS is expected to grow by 30.3% per annum. Return on equity is forecast to be 21.9% in 3 years. Inozyme Pharma falls after updates to rare disease program. Jul. 26, 2023 10:24 AM ET Inozyme Pharma, Inc. (INZY) By: Dulan Lokuwithana, SA News Editor. mphillips007. Inozyme Pharma ( NASDAQ: INZY ...Nov 20, 2023 · Target values for the price of one Incyte share for Jan 2025. The weighted average target price per Incyte share in Jan 2025 is: 59.50. In Jan, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 7.054% volatility is expected. Pessimistic target level: 56.44. Optimistic target level: 60.73. Complete Inozyme Pharma Inc. stock information by Barron's. View real-time INZY stock price and news, along with industry-best analysis.Nasdaq Futures 16,054.50 +30.75(+0.19%) Russell 2000 Futures 1,807.30 +1.50(+0.08%) Crude Oil 77.85 -0.01(-0.01%) Gold 2,065.80 -1.30(-0.06%) Inozyme Pharma, Inc. (INZY) …A high-level overview of Inozyme Pharma, Inc. (INZY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.The high estimate for the stock price was $93.00, while the low estimate was $58.00. This indicates a potential increase of 32.98% from the last recorded price of $53.39. The consensus among 23 polled investment analysts is to hold the stock in Incyte Corp. This rating has remained steady since November, when it was downgraded from a buy rating.Find the latest Cano Health, Inc. (CANO) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Dogecoin USD (DOGE-USD) price quote, history, news and other vital information to help you with your cryptocurrency trading and investing.Find the latest Avenue Therapeutics, Inc. (ATXI) stock quote, history, news and other vital information to help you with your stock trading and investing.INCY Earnings Date and Information. Incyte last announced its earnings results on October 31st, 2023. The biopharmaceutical company reported $0.91 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.91. The company earned $919.03 million during the quarter, compared to the consensus estimate of …Find the latest China SXT Pharmaceuticals, Inc. (SXTC) stock quote, history, news and other vital information to help you with your stock trading and investing.Analyst Forecast According to 16 analysts, the average rating for INCY stock is "Buy." The 12-month stock price forecast is $79.25, which is an increase of 46.71% from the latest price.Stock Price Forecast. The 15 analysts offering 12-month price forecasts for Paycom Software Inc have a median target of 190.00, with a high estimate of 270.00 and a low estimate of 140.00. The ...See Inozyme Pharma, Inc. (INZY) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.The 16 Wall Street analysts offering INCYTE CORP stock forecast in the last 6 months have average price target of $78.88 with a high forecast of $98.0 and a low forecast of $63.0. The average INCYTE CORP stock forecast represents a 46.78% increase from the last price of $53.7400016784668.According to our current INZY stock forecast, the value of Inozyme Pharma shares will rise by 7.27% and reach $ 3.50 per share by November 24, 2023. According to our technical indicators, the current sentiment is Bearish while the Fear & Greed Index is showing 39 (Fear).Track Inozyme Pharma Inc (INZY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Title. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result ... INZY is trading at a 62% discount. Price $3.79 Nov 21, 2023 Fair Value $3.12 Nov 21, 2023 Uncertainty Extreme 1-Star Price $45.55Delayed Data. As of Nov 16. +0.03 / +0.94%. Today’s Change. 0.99. Today ||| 52-Week Range. 7.33. +207.62%. Year-to-Date.A high-level overview of Inozyme Pharma, Inc. (INZY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Find the latest Insider Activity data for Inozyme Pharma, Inc. Common Stock (INZY) at Nasdaq.com.Find the latest China SXT Pharmaceuticals, Inc. (SXTC) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Cano Health, Inc. (CANO) stock quote, history, news and other vital information to help you with your stock trading and investing.View the latest INZY earnings date, analysts forecasts, earnings history, and conference call transcripts. Skip to main content. S&P 500 4,594.63. DOW 36,245.50. QQQ 389.94. ... Stock Ideas and Recommendations. Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine.Get the latest Inozyme Pharma Inc (INZY) stock quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. See the company's financial results, market news, and earnings per share for the fiscal Q2 2023 ended 6/30/23. Find the latest OKYO Pharma Limited (OKYO) stock quote, history, news and other vital information to help you with your stock trading and investing.The firm owned 605,555 shares of the company’s stock after selling 69,848 ... Equities analysts forecast that Dynatrace, Inc. will post 0.58 ... INZY) Rock Springs Capital Management ...American Electric Power. Cramer said that he likes the stock because the company is well-run, and utility stocks tend to perform well during economic slowdowns. Dollar Tree. While he does like the ...Find the latest Phathom Pharmaceuticals, Inc. (PHAT) stock quote, history, news and other vital information to help you with your stock trading and investing.SEMR | Complete SEMrush Holdings Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Find the latest Vyant Bio, Inc. (VYNT) stock quote, history, news and other vital information to help you with your stock trading and investing.Federated Hermes: bullish, S&P 500 price target of 5,000. Strong underlying trends in the stock market are likely to extend well into 2024, according to Federated …. Kraken robotics stock